Pacific Biosciences Of California reported $645.38M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agilent USD 3.05B 1000K Mar/2026
Bruker USD 1.66B 189.6M Mar/2026
Danaher USD 17.56B 855M Mar/2026
General Electric Aerospace USD 18.17B 634M Mar/2026
Illumina USD 1.49B 0 Mar/2026
Myriad Genetics USD 120.3M 400K Mar/2026
Pacific Biosciences Of California USD 645.38M 223K Dec/2025
Quidel USD 0 2.47B Mar/2026
Revvity USD 2.63B 836K Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Standard Biotools USD 299K 0 Dec/2025
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Waters USD 5.22B 3.81B Mar/2026